Results 201 to 210 of about 5,397,691 (379)
Family history in the Aetiology of Gestational Diabetes Mellitus and Type 2 Diabetes [PDF]
, 2003 The aetiology of Type 2 diabetes [NIDDM] is assumed to involve a multiplicity of causal factors involving both genetic and environmental, including intrauterine, components. Aim: To identify the relationship of various aspects of family history and hence
Chircop, Marcelle +2 more
core
Matrix Tropism Influences Endometriotic Cell Attachment Patterns
Advanced Functional Materials, EarlyView.The influence of substrate stiffness and multicellular coculture on endometriotic cell attachment to extracellular matrix‐laden microarrayed islands is reported. This model investigates early endometriotic cell attachment, aiming to capture “lesion initiation events”.
Hannah S. Theriault +7 more
wiley +1 more source
Non-esterified fatty acids do not contribute to insulin resistance in persons at increased risk of developing Type 2 (non-insulin-dependent) diabetes mellitus [PDF]
, 1991 Johan G. Eriksson +6 more
openalex +1 more source
Advanced Functional Materials, EarlyView.CD105‐LNPs and PS‐LNPs can deliver α‐lipoic acid to bone marrow mesenchymal stem cells and bone marrow‐derived macrophages, reversing high glucose‐induced oxidative stress while enhancing osteogenesis and M2 polarization. Integrating both nanoparticles into glucose‐responsive hyaluronic acid hydrogel forms DLNPs@HA hydrogel, which accelerates diabetic ...
Yanzhi Zhao +11 more
wiley +1 more source
Pharmacogenetics in type 2 diabetes
Clinical Management Issues, 2012 Antonio Brunetti
doaj +1 more source
Untreated Type 2 Diabetes as a Cause of Daytime Somnolence [PDF]
, 1993 Irwin Feinberg
openalex +1 more source
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
New England Journal of Medicine, 2016 M. Fischereder, U. Schönermarck
semanticscholar +1 more source
Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John +5 more
wiley +1 more source
A fresh look at NIDDM. A report from the 3rd International Symposium on Type 2 diabetes: Copenhagen, Denmark: May 10‐11th 1993 [PDF]
, 1993 Roslyn Elson
openalex +1 more source